Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD20m

    Last close

    USD3.57

    ▲ −2.08 (−36.81%)

    Faraday Future Intelligent Electric

    MCap

    USD10m

    Last close

    USD3.92

    ▲ −0.76 (−16.24%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sareum Holdings – executive interview

Sareum Holdings – executive interview

Sareum Holdings — 5 videos in collection

More on this equity

Sareum Holdings (AIM: SAR) is a UK-listed drug-discovery company focused on the development of small molecule kinase inhibitors. Its in-house programmes are dual TYK2/JAK1 inhibitors: SDC-1801 for autoimmune diseases and SDC-1802 for cancer. The third development programme is SRA737, a CHK1 inhibitor targeting the DNA damage response network for the treatment of solid tumours. Sareum holds a 27.5% economic interest in SRA737.

In this video, we talk to Dr Stephen Parker, executive chairman at Sareum, about the potential to offer differentiation with SDC-1801’s dual inhibition approach, the recently presented positive Phase I data for the candidate, as well as next steps, which include plans for Phase II. We also discuss the company’s £3.4m equity raise, how the funds will be deployed to advance all pipeline assets through next stages of clinical development and key milestones for investors to watch out for.

< Previous
Next >

You may also be interested in these:

Healthcare

Sareum – executive interview

Healthcare

Sareum Holdings – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.